Published in Cardiovasc Drugs Ther on April 01, 1989
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl (2000) 2.52
Percutaneous coronary excimer laser angioplasty in patients with stable and unstable angina pectoris. Acute results and incidence of restenosis during 6-month follow-up. Circulation (1990) 2.05
Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med (1996) 1.73
Plasma clearance of iodine contrast media as a measure of glomerular filtration rate in critically ill patients. Crit Care Med (2001) 1.70
Upregulation of cholesterol synthesis after acute myocardial infarction--is cholesterol a positive acute phase reactant? Atherosclerosis (1999) 1.58
Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry. Z Kardiol (2004) 1.53
Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment. J Am Coll Cardiol (1999) 1.49
The "point of no return" and the rate of progression in the natural history of IgA nephritis. Clin Nephrol (1999) 1.49
[Contrast media-induced kidney failure cannot be prevented by hemodialysis]. Dtsch Med Wochenschr (2001) 1.43
Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems. J Intern Med (1993) 1.43
Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry (1994) 1.41
Percutaneous coronary interventions using a new 5 French guiding catheter: results of a prospective study. Catheter Cardiovasc Interv (2001) 1.39
Prognosis and possible presymptomatic manifestations of congestive cardiomyopathy (COCM). Postgrad Med J (1978) 1.28
Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs (1999) 1.26
Platelets, inflammation and atherosclerosis. J Thromb Haemost (2007) 1.22
Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci U S A (2000) 1.20
Prognostic significance of late ventricular potentials after acute myocardial infarction. Eur Heart J (1983) 1.15
Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol (2000) 1.12
Massive cavernous lymphangioma of the breast and thoracic wall: case report and literature review. Lymphology (2006) 1.11
Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients. Ann Oncol (2012) 1.11
[Hypercalcaemic crisis and acute renal failure due to primary hyperparathyroidism]. Dtsch Med Wochenschr (2008) 1.10
Recording of left atrial potentials from pulmonary artery in man. Br Heart J (1980) 1.09
Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomide. Clin Rheumatol (2007) 1.08
Platelet protection in coronary artery surgery: benefits of heparin-coated circuits and high-dose aprotinin therapy. J Cardiothorac Vasc Anesth (1999) 1.08
Influence of ribose, adenosine, and "AICAR" on the rate of myocardial adenosine triphosphate synthesis during reperfusion after coronary artery occlusion in the dog. Circ Res (1985) 1.07
Comparison and accuracy of methods to determine the confocal volume for quantitative fluorescence correlation spectroscopy. J Microsc (2008) 1.06
What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol (2004) 1.06
[Hypercalcemic crisis due to primary hyperparathyroidism]. Dtsch Med Wochenschr (2008) 1.06
Effects of verapamil on sinus node function in man. Eur J Cardiol (1978) 1.04
Allogenic bone graft viability after hip revision arthroplasty assessed by dynamic [18F]fluoride ion positron emission tomography. Eur J Nucl Med (1999) 1.03
The serine/threonine kinases SGK2 and SGK3 are potent stimulators of the epithelial Na+ channel alpha,beta,gamma-ENaC. Pflugers Arch (2003) 1.03
Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation. J Cardiovasc Electrophysiol (2000) 1.00
Influence of sampling site and flow area on cardiac output measurements by Doppler echocardiography. J Am Coll Cardiol (1987) 0.99
Sinus node recovery time and calculated sinoatrial conduction time in normal subjects and patients with sinus node dysfunction. Circulation (1977) 0.98
Atrial septal defect in adults: cardiopulmonary exercise capacity before and 4 months and 10 years after defect closure. J Am Coll Cardiol (1997) 0.98
Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant (1999) 0.98
Function of the p55 tumor necrosis factor receptor "death domain" mediated by phosphatidylcholine-specific phospholipase C. J Exp Med (1996) 0.96
Relationship between the degree of coronary artery disease and of left ventricular function and the duration of the QT-interval in ECG. Eur Heart J (1986) 0.96
Accurate local blood flow measurements with dynamic PET: fast determination of input function delay and dispersion by multilinear minimization. J Nucl Med (1993) 0.96
Thrombolytic therapy in acute myocardial infarction: comparison of procoagulant effects of streptokinase and alteplase regimens with focus on the kallikrein system and plasmin. Circulation (1998) 0.94
Non-invasive detection of late potentials in man--a new marker for ventricular tachycardia. Eur Heart J (1981) 0.93
Successful transplantation of highly selected CD34+ peripheral blood stem cells in a HLA-sensitized patient treated with immunoadsorption onto protein A. Transplantation (2000) 0.93
[Electrophysiological effects of the new antiarrhythmic drug flecainide (R 818) in man (author's transl)]. Z Kardiol (1981) 0.93
Tricuspid valve endocarditis due to a jet lesion detected by echocardiography in a 27-year old man with congenital ventricular septal defect. J Cardiovasc Surg (Torino) (1996) 0.92
[18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I]. Nuklearmedizin (1995) 0.92
Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2. Am J Physiol Renal Physiol (2000) 0.91
Repeated short periods of regional myocardial ischemia: effect on local function and high energy phosphate levels. Basic Res Cardiol (1986) 0.91
Molecular cloning and characterization of human kinectin. Mol Biol Cell (1995) 0.90
Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization. Int J Cardiol (2005) 0.90
Multifactorial genesis of enhanced platelet aggregability in patients with nephrotic syndrome. Kidney Int (1989) 0.90
Late complications in patients with Björk-Shiley and St. Jude Medical heart valve replacement. Circulation (1983) 0.89
[Low-dose enalapril in severe chronic heart failure]. Z Kardiol (1991) 0.89
Acute effects of hemodialysis on cytokine transcription profiles: evidence for C-reactive protein-dependency of mediator induction. Kidney Int (2006) 0.89
Propafenone--a new antiarrhythmic drug. Eur Heart J (1980) 0.89
[Differential diagnosis of cyanosis. Familial methemoglobin-reductase deficiency]. Med Welt (1971) 0.89
Accuracy of Doppler echocardiography in quantification of left to right shunts in adult patients with atrial septal defect. J Am Coll Cardiol (1988) 0.89
Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society. Z Kardiol (2005) 0.88
Prevention of radiocontrast-induced nephropathy by adenosine antagonists in rats with chronic nitric oxide deficiency. J Am Soc Nephrol (1997) 0.88
Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int (1994) 0.88
Time course of changes in ventricular fibrillation threshold in myocardial infarction: characteristics of acute and slow occlusion with respect to the collateral vessels of the heart. Cardiovasc Res (1976) 0.88
[Sonographic criteria for the differentiation of benign and malignant breast lesions using real-time spatial compound imaging in combination with XRES adaptive image processing]. Ultraschall Med (2010) 0.88
Nuclear hourglass technique: an approach that detects electrically open nuclear pores in Xenopus laevis oocyte. Proc Natl Acad Sci U S A (1999) 0.87
Determinants of the incidence and severity of ventricular arrhythmias in aortic valve disease. Am J Cardiol (1983) 0.87
Molecular and electrophysiological evidence for "remodeling" of the L-type Ca2+ channel in persistent atrial fibrillation in humans. Z Kardiol (2000) 0.87
Subacute myocardial infarction: assessment by STIR T2-weighted MR imaging in comparison to regional function. MAGMA (2001) 0.86
[Significance of electrocardiography in the diagnosis and course observation of patients with congestive cardiomyopathy]. Z Kardiol (1974) 0.86
Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris. Circulation (1995) 0.86
Manifestation of severe coronary heart disease after anabolic drug abuse. Clin Cardiol (1996) 0.86
Association of glomerular and interstitial mononuclear leukocytes with different forms of glomerulonephritis. Nephrol Dial Transplant (1990) 0.86
Mechanisms and clinical significance of cell volume regulation. Nephrol Dial Transplant (1998) 0.85
Functional characterization of the Betaine/gamma-aminobutyric acid transporter BGT-1 expressed in Xenopus oocytes. J Biol Chem (1999) 0.85
Effect of adenosine and AICAR on ATP content and regional contractile function in reperfused canine myocardium. Basic Res Cardiol (1985) 0.85
The selective adenosine A1 receptor antagonist KW-3902 prevents radiocontrast media-induced nephropathy in rats with chronic nitric oxide deficiency. Eur J Pharmacol (2001) 0.85
Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia. J Cardiovasc Pharmacol (1981) 0.85
Electrophysiologic effects and efficacy of cibenzoline on stimulation-induced atrial fibrillation and flutter and implications for treatment of paroxysmal atrial fibrillation. Am J Cardiol (1990) 0.84
Radiation-induced heart disease: morphology, changes in catecholamine synthesis and content, beta-adrenoceptor density, and hemodynamic function in an experimental model. Radiat Res (1992) 0.84
Surgical treatment of ventricular tachycardias. Complete versus partial encircling endocardial ventriculotomy. J Thorac Cardiovasc Surg (1984) 0.83
The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study. Nephrol Dial Transplant (2001) 0.83
Effect of extracellular pH on the myo-inositol transporter SMIT expressed in Xenopus oocytes. Pflugers Arch (1998) 0.83
[Effect of flecainide on chronic ventricular arrhythmias (author's transl)]. Z Kardiol (1982) 0.83
Effects of antihypertensive therapy on blood pressure and renal function in rats with hypertension due to chronic blockade of nitric oxide synthesis. Exp Nephrol (1995) 0.83
Aortic valve endocarditis with paravalvular abscesses caused by Erysipelothrix rhusiopathiae. Eur J Clin Microbiol Infect Dis (2001) 0.83
[Which rhythm disturbances react to beta blockaders?]. Cardiology (1978) 0.83
[Cholestasis after antiarrhythmic therapy with propafenone]. Dtsch Med Wochenschr (1984) 0.83
Late outcome of survivors of idiopathic ventricular fibrillation. Am J Cardiol (1998) 0.83
Metaiodobenzylguanidine (MIBG) labeled with 123I/131I in neuroblastoma diagnosis and follow-up treatment with a review of the diagnostic results of the International Workshop of Pediatric Oncology held in Rome, September 1986. Med Pediatr Oncol (1987) 0.83
[Twiddler-Syndrome in a subpectoral implanted unipolar cardioverter-defibrillator]. Z Kardiol (1998) 0.82
Ventricular fibrillation induced by a unipolar implanted pacemaker (cathodal stimulation). Am Heart J (1976) 0.82
Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. J Cardiovasc Electrophysiol (1999) 0.82
Streptokinase-induced activation of the kallikrein-kinin system and of the contact phase in patients with acute myocardial infarction. J Cardiovasc Pharmacol (1998) 0.82
Endothelial function, variables of fibrinolysis and coagulation in smokers and healthy controls. Haemostasis (2000) 0.82
The correlation between blood pressure and morphometric findings in children with congenital heart disease and pulmonary hypertension. Basic Res Cardiol (1982) 0.82
Cellular taurine release triggered by stimulation of the Fas(CD95) receptor in Jurkat lymphocytes. Pflugers Arch (1998) 0.82
Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment. Int J Cardiol (1999) 0.82
Effect of a single element subcutaneous array electrode added to a transvenous electrode configuration on the defibrillation field and the defibrillation threshold. Pacing Clin Electrophysiol (1998) 0.81
Spontaneous splenic rupture complicating acute Q fever. Am J Gastroenterol (1992) 0.81
Detection of infection in postoperative orthopedic patients with technetium-99m-labeled monoclonal antibodies against granulocytes. J Nucl Med (1991) 0.81